Tag: oral immunotherapy (OIT)

Peanuts

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for...

An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.
AR101

New Treatment to Protect People with Peanut Allergies Ready for FDA...

"Two thirds of the people in the study were able to tolerate the equivalent of two peanuts per day after 9 to 12 months of treatment."
Christopher Ryan and Friends

Teen Undergoes Peanut OIT to Join Marines

“I’m not taking no for an answer...."
Wheat

Mount Sinai Researchers Find Wheat Oral Immunotherapy to Be Therapeutic for...

First multicenter rigorous clinical trial yields promising results.
AR101+dupilumab

Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...

Trial Will Build on the Positive, Pivotal Phase 3 PALISADE Trial of AR101.
AR101+dupilumab

Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...

Study scheduled to commence next week.
Baby OIT

ACAAI: Advice to Allergists Regarding Private Practice OIT

Although intended for allergists, a good read for families considering OIT as well.
Elise and Laura

Teen Saves Best Friend Suffering Anaphylaxis

"These are two very brave girls!"
AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
OIT

Study: Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents

Child’s food allergies have major impact on parents’ lives; majority of parents are willing to enroll their child in an immunotherapy clinical trial

Connect with Us

34,863FansLike
95FollowersFollow
196FollowersFollow
2,317FollowersFollow
5,194FollowersFollow
37SubscribersSubscribe